Accuray Inc income statement
In fiscal 2026, Accuray Inc reported revenue of $402m, down 12.3% on the year before, operating income of −$26.4m (a -6.6% margin) and net income of −$49.2m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2010Jun 2010 | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 222 | 222 | 409 | 316 | 369 | 380 | 399 | 383 | 405 | 419 | 383 | 396 | 430 | 448 | 447 | 459 | 402 |
| Cost of revenue | 118 | 115 | 272 | 218 | 227 | 234 | 240 | 242 | 243 | 256 | 233 | 237 | 270 | 294 | 304 | 312 | 290 |
| Gross profit | 104 | 107 | 137 | 98 | 143 | 145 | 159 | 141 | 162 | 163 | 150 | 160 | 160 | 154 | 143 | 147 | 111 |
| Research and development | 32 | 41 | 81 | 66 | 54 | 56 | 57 | 50 | 57 | 56 | 50 | 53 | 58 | 57 | 50 | 48 | 38 |
| Selling and marketing | 34 | 37 | 55 | 54 | 62 | 62 | 57 | 57 | 60 | 56 | 47 | 43 | 50 | 46 | 43 | 43 | 39 |
| General and administrative | 35 | 57 | 58 | 58 | 45 | 46 | 50 | 44 | 48 | 50 | 40 | 42 | 44 | 48 | 50 | 48 | 45 |
| Operating income | 3 | −28 | −56 | −81 | −18 | −19 | −5 | −10 | −4 | 1 | 13 | 22 | 8 | 2 | 1 | 8 | −26 |
| Interest expense | — | — | 7 | 10 | 14 | 17 | 17 | 17 | 15 | 15 | 18 | 17 | 8 | 11 | 12 | 13 | 33 |
| Provision for credit losses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | −0 | −0 | 1 |
| Income before tax | 3 | −26 | −69 | −94 | −32 | −38 | −23 | −29 | −23 | −14 | 6 | −5 | −2 | −7 | −12 | 1 | −47 |
| Income tax | −0 | 1 | 3 | 4 | 3 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 4 | 3 | 2 |
| Net income | 3 | −27 | −72 | −103 | −35 | −40 | −26 | −30 | −24 | −16 | 4 | −6 | −5 | −9 | −16 | −2 | −49 |
| Diluted EPS | $0.05 | −$0.44 | −$1.02 | −$1.41 | −$0.47 | −$0.51 | −$0.32 | −$0.36 | −$0.28 | −$0.19 | $0.04 | −$0.07 | −$0.06 | −$0.10 | −$0.16 | −$0.02 | — |
| Diluted shares (average) | 60m | 60m | 71m | 73m | 76m | 78m | 81m | 82m | 85m | 87m | 91m | 92m | 92m | 95m | 98m | 103m | 123m |
| EBITDA | 10 | −20 | −24 | −55 | 2 | 0 | 13 | 8 | 6 | 11 | 20 | 29 | 14 | 7 | 6 | 14 | −19 |
| Quarter | 2025 Q1Sept 2024 | 2025 Q2Dec 2024 | 2025 Q3Mar 2025 | 2025 Q4Jun 2025 | 2026 Q1Sept 2025 | 2026 Q2Dec 2025 | 2026 Q3Mar 2026 | 2026 Q4Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 102 | 116 | 113 | 128 | 94 | 102 | 105 | 101 |
| Cost of revenue | 67 | 74 | 82 | 89 | 67 | 78 | 80 | 66 |
| Gross profit | 34 | 42 | 32 | 39 | 27 | 24 | 25 | 35 |
| Research and development | 12 | 14 | 11 | 11 | 11 | 11 | 8 | 8 |
| Selling and marketing | 12 | 11 | 9 | 11 | 12 | 9 | 8 | 10 |
| General and administrative | 13 | 12 | 11 | 12 | 15 | 10 | 11 | 12 |
| Operating income | −2 | 5 | 1 | 4 | −11 | −12 | −9 | 6 |
| Interest expense | 3 | 3 | 3 | 4 | 8 | 8 | 8 | 9 |
| Provision for credit losses | 0 | 0 | −0 | −0 | 1 | −0 | −0 | −0 |
| Income before tax | −3 | 3 | −1 | 2 | −21 | −13 | −11 | −2 |
| Income tax | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
| Net income | −4 | 3 | −1 | 1 | −22 | −14 | −12 | −2 |
| Diluted EPS | −$0.04 | $0.02 | −$0.01 | $0.01 | −$0.18 | −$0.11 | — | — |
| EBITDA | −1 | 6 | 3 | 6 | −10 | −10 | −7 | 8 |
Compare with peers
- Inmode Ltd. income statement
- Tactile Systems Technology Inc income statement
- Inogen Inc income statement
- Artivion, Inc. income statement
- Staar Surgical Co income statement
Head to head: ARAY vs INMDARAY vs TCMDARAY vs INGNAORT vs ARAY
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies